Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
Two tranches: 60,000 shares @ $13.017 on 9/14 ($781K) + 340,000 shares @ $13.038 on 9/16 ($4.43M). Purchased via Ventus Capital LLC. Robo is former CEO of NextEra Energy and current Chairman of KBDC. Not a 10b5-1 plan. Current price $13.05 (+0.2% vs avg buy). Total indirect holding rises to 400,000 shares via Ventus Capital; also holds 1,738,174 shares through Ventus Capital KABDC LLC.
Weighted avg $68.78 (range $68.74–$68.81). Filed same day as CEO Joey Agree buy — cluster signal. Post-transaction direct holdings: 654,602 shares. Current price $68.50 (-0.4% vs buy price).
Three-day accumulation: 40,373 sh @ $8.696 (9/14), 3,375 sh @ $8.54 (9/15), 80,170 sh @ $8.51 avg (9/16). Total beneficial ownership now 3,272,141 shares. Opaleye has been buying ACOG throughout 2026 — ongoing conviction in Alzheimer's drug Zunveyl. Current price $8.40 (-2.0% vs avg buy).
Weighted avg $68.06 (range $67.97–$68.13) on 9/16. Cluster with Rakolta Director buy same day — combined $1.88M into ADC. Post-transaction direct holdings: 682,465 shares. Current price $68.50 (+0.6% vs buy price).
15,000 shares @ $28.27 (EUR 24.50 equivalent) on 9/15 via parallel offering for SBLK's dual listing on Euronext Athens. Not a traditional open-market purchase — tied to the Greece listing event. Post-transaction holdings: 241,200 shares. Current price $30.87 (+9.2% vs buy price).
AIThe day in insider buying
SEC Form 4 Insider Scan — September 17, 2026
Scanned the last 24 hours of EDGAR Form 4 filings (filed 2026-09-16 through 2026-09-17). 5 qualifying buys (≥ $250K, transaction type P) totalling $8.58M.
Headline Filings
KBDC — James L. Robo (Director/Chairman, via Ventus Capital LLC) bought 400,000 shares ≈ $5.21M at $13.03 avg; now $13.05 (+0.2% since buy). Two tranches: 60K shares on 9/14 + 340K shares on 9/16. New position. (filing)
ADC — John Rakolta Jr. (Director) bought 20,000 shares ≈ $1.38M at $68.78 avg; now $68.50 (-0.4% since buy). Adding to existing 634K-share position. Filed same day as CEO buy — cluster signal. (filing)
ACOG — Opaleye Management Inc. (10% Owner) bought 123,918 shares ≈ $1.06M at $8.57 avg; now $8.40 (-2.0% since buy). Three-day accumulation campaign (9/14–9/16), continuing a pattern of steady buying throughout 2026. (filing)
ADC — Joey Agree (President & CEO) bought 7,360 shares ≈ $501K at $68.06 avg; now $68.50 (+0.6% since buy). Cluster with Rakolta buy on same date. (filing)
SBLK — Symeon Spyrou (Co-CFO) bought 15,000 shares ≈ $424K at $28.27; now $30.87 (+9.2% since buy). Purchased via parallel offering in Greece as part of Star Bulk's dual-listing on Euronext Athens. (filing)
Also Notable (Filed Sept 15 — just outside 24h window)
CELH — Damon DeSantis (Director) bought 36,000 shares ≈ $1.00M at $27.82 avg; now $28.25 (+1.5%). Director conviction buy in Celsius Holdings.
RWT — Christopher Abate (CEO) bought 100,000 shares ≈ $385K at $3.84; now $3.89 (+1.3%). CEO open-market buy in Redwood Trust.
Notes
Cluster signal in ADC (Agree Realty): Both the CEO and a major director bought on the same day (Sept 16) — combined $1.88M into the REIT. This is the strongest conviction signal of the day. ADC is a net-lease REIT yielding ~4.5%.
KBDC new position: James Robo (former NextEra CEO, chairman of Kayne Anderson BDC) built a $5.2M position through his Ventus Capital vehicle — notably not a routine 10b5-1 transaction. KBDC is a BDC trading near NAV at ~$13.
ACOG persistence: Opaleye Management has been buying Alpha Cognition aggressively throughout 2026, suggesting high conviction in the company's Alzheimer's drug Zunveyl.
SBLK context: The Euronext Athens parallel offering purchase should be read in context of the dual-listing event rather than as a spontaneous open-market conviction buy, though CFO participation is still notable.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.